VERACYTE, INC. (VCYT) insider trading

By person

30 insiders · 387 transactions

30.8×

Marc Stapley holds 30.8 times base salary in stock. $21.61M of shares against $700.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Marc Stapley last reported holding, valued at $50.00, the price Common Stock was last bought or sold at on the open market here, on 27 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Jesse I Treu

Director

—

$26.86M (13)

−$26.86M

1,236,571

1.54%

$61.83M

−56.0%

Bonnie H Anderson

Director

—

$26.05M (66) scheduled

−$26.05M

396,606

0.4933%

$19.83M

+69.7%

Evan/ Fa Jones

Director

—

$12.28M (53)

−$12.28M

104,287

0.1297%

$5.21M

−75.1%

Giulia C Kennedy

Chief Scientific & Med Officer

—

$12.22M (53) scheduled

−$12.22M

65,970

0.0821%

$3.30M

+601.3%

Marc Stapley

Chief Executive Officer

$980.09K (1)

$11.15M (11) scheduled

−$10.17M

432,073

0.5375%

$21.61M

+7,904%

Christopher M Hall

President and COO

—

$6.66M (15) scheduled

−$6.66M

28,258

0.0352%

$1.41M

—

John Walter Hanna JR

Chief Commercial Officer

—

$6.47M (19) scheduled

−$6.47M

73,844

0.0919%

$3.69M

+10.3%

Karin Eastham

Director

—

$5.62M (31) scheduled

−$5.62M

14,647

0.0182%

$732.42K

−16.9%

Keith Kennedy

COO / CFO

—

$4.22M (8) scheduled

−$4.22M

116,858

0.1454%

$5.84M

+1,131%

Rebecca Chambers

Chief Financial Officer

—

$2.82M (12) scheduled

−$2.82M

166,025

0.2065%

$8.30M

+9,113%

Annie McGuire

EVP, General Counsel

—

$2.74M (17) scheduled

−$2.74M

131,160

0.1632%

$6.56M

+8,535%

John Leite

Global Chief Commercial Off

—

$2.08M (13) scheduled

−$2.08M

124,329

0.1547%

$6.22M

+199.8%

Robert S Epstein

Director

—

$2.07M (6) scheduled

−$2.07M

57,718

0.0718%

$2.89M

—

Jonathan Wygant

VP, Chief Accounting Officer

—

$1.80M (5) scheduled

−$1.80M

41,920

0.0521%

$2.10M

+166.2%

Phillip G. Febbo

Chief Scientific & Med Officer

—

$1.79M (7) scheduled

−$1.79M

133,048

0.1655%

$6.65M

—

Jens Holstein

Director

$70.39K (1)

$1.77M (11) scheduled

−$1.69M

27,471

0.0342%

$1.37M

—

Kevin K Gordon

Director

—

$1.24M (5) scheduled

−$1.24M

8,720

0.0108%

$436.04K

—

Fred E Cohen

Director

—

$1.07M (2)

−$1.07M

10,000

0.0124%

$500.05K

—

Mark Ho

Principal Accounting Officer

—

$624.38K (1)

−$624.38K

71,728

0.0892%

$3.59M

+199.3%

John L Bishop

Director

—

$605.00K (2) scheduled

−$605.00K

33,125

0.0412%

$1.66M

—

Muna Bhanji

Director

—

$590.53K (8) scheduled

−$590.53K

40,854

0.0508%

$2.04M

—

Kleiner Perkins Caufield & Byers Xii, LLC entity

10% owner

—

2,801,929

3.49%

$140.11M

−21.1%

Tina Susan Nova

President, CLIA U.S.

—

76,988

0.0958%

$3.85M

+147.3%

Eliav Barr

Director

—

56,461

0.0702%

$2.82M

—

Kevin Richard Haas

Chief Dev and Tech Officer

—

44,221

0.0550%

$2.21M

—

David Brent Shafer

Director

—

31,100

0.0387%

$1.56M

—

Thomas F. Miller

Director

—

31,100

0.0387%

$1.56M

—

Beverly Jane Alley

VP, Corporate Controller

—

13,000

0.0162%

$650.06K

+73.3%

III James H Erlinger

EVP, General Counsel

—

7,500

0.0093%

$375.04K

—

Julie Brooks

EVP, Gen Counsel and Secretary

—

4,162

0.0052%

$208.12K

+10.0%

VERACYTE, INC.

What the insiders did Net selling

By person